Esophageal Neoplasms: all 1,631 studies
Page 16 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryTerminatedNCT00290719Phase 1
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00281788Phase 1
- Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal CancerCompletedNCT00281736Phase 2
- The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyCompletedNCT00270166Phase 3
- Oxaliplatin in Esophagus Cancer (Advanced) 1st LineCompletedNCT00259402Phase 2
- Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction CancerCompletedNCT00258323Phase 2
- Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By SurgeryTerminatedNCT00258297Phase 2
- Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction CarcinomaTerminatedNCT00256269Phase 2
- Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma EsophagusTerminatedNCT00239200Phase 2
- Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By SurgeryCompletedNCT00238407Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal CancerCompletedNCT00238147Phase 1
- Pre-operative Chemotherapy and Radiation Therapy for Esophageal CarcinomaCompletedNCT00230451Phase 2
- Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNCT00220129Phase 2
- Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal CancerStatus unknownNCT00220077Not applicable
- Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasCompletedNCT00215995Phase 2
- Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II TrialCompletedNCT00213486Phase 2
- Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.CompletedNCT00209716Phase 1/2
- Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.CompletedNCT00209690Phase 1/2
- Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusTerminatedNCT00208936Phase 2
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerCompletedNCT00201747Phase 2
- Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal CancerCompletedNCT00197444Phase 2
- Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.CompletedNCT00193882Phase 3
- Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective TrialStatus unknownNCT00193817Phase 3
- Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal CancerCompletedNCT00193141Phase 2
- A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell CarcinomaTerminatedNCT00190554Phase 3
- A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal CancerTerminatedNCT00183807Phase 2
- Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
- Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerCompletedNCT00165464Phase 2
- Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)CompletedNCT00165061Phase 3
- Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal CancerCompletedNCT00160875Phase 2/3
- Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal CancerCompletedNCT00160030Phase 2
- CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal CancerCompletedNCT00154804Phase 2
- Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal CancerCompletedNCT00154700Phase 2
- Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal CancerCompletedNCT00153881Phase 1
- Selective Dose Escalation for Esophageal CancerStatus unknownNCT00139633Phase 2
- Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal CancerCompletedNCT00137852Phase 2
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00107341Phase 2
- Gefitinib in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00100945Phase 2
- FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT00098527Phase 2
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNCT00094978Phase 1
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNCT00093652Phase 1/2
- 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionCompletedNCT00077545Phase 2
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal CancerStatus unknownNCT00075738Phase 2
- Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00072332Phase 1
- Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal CancerCompletedNCT00072033Phase 2
- Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the EsophagusCompletedNCT00066716Phase 2
- Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00061958Phase 2
- Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal TumorsCompletedNCT00060268Phase 1/2
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesStatus unknownNCT00057395Phase 1/2
- Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerCompletedNCT00054873Phase 2
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
- Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal CancerCompletedNCT00051480Phase 2
- Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusSuspendedNCT00048529Phase 2
- Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal CancerCompletedNCT00047112Phase 3
- Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00045526Phase 2
- Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal CancerCompletedNCT00042510Phase 2
- Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
- Combination Chemotherapy in Treating Patients With Esophageal CancerStatus unknownNCT00041262Phase 3
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00040859Phase 2
- A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal CancerStatus unknownNCT00037089Phase 2
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00032123Phase 2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedNCT00030862Phase 2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerWithdrawnNCT00025532Phase 1
- Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00022139Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00021320Phase 2
- Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop SmokingCompletedNCT00021138Not applicable
- Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal CancerCompletedNCT00020787Phase 3
- Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachCompletedNCT00020761Phase 2
- Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraCompletedNCT00019825Phase 1
- Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
- LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNCT00019435Phase 1
- Vaccine Therapy in Treating Patients With Advanced or Recurrent CancerCompletedNCT00019110Phase 1
- DX-8951f in Treating Patients With Metastatic Stomach CancerCompletedNCT00017212Phase 2
- BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With ChemotherapyCompletedNCT00017056Phase 2
- BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyCompletedNCT00017043Phase 2
- PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedNCT00016900Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
- S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusCompletedNCT00012363Phase 2
- Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractTerminatedNCT00012246Phase 2
- Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone SurgeryCompletedNCT00011960Phase 2
- LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerStatus unknownNCT00010270Phase 1
- Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00009880Phase 2
- Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the EsophagusStatus unknownNCT00008047Phase 1/2
- Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal CancerTerminatedNCT00006472Phase 2
- Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous PaclitaxelCompletedNCT00006245Phase 2
- Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerCompletedNCT00006081Phase 2
- Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00006038Phase 2
- Celecoxib to Prevent Cancer in Patients With Barrett's EsophagusCompletedNCT00005878Phase 2
- Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00005876Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00005638Phase 1
- Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusStatus unknownNCT00005607Phase 2
- Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00005599Phase 2
- Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal CancerTerminatedNCT00004897Phase 2
- Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerCompletedNCT00004879Phase 1
- Positron Emission Tomography in Determining Stage of Esophageal CancerCompletedNCT00004867Not applicable
- Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach CancerCompletedNCT00004257Phase 1
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerStatus unknownNCT00004236Phase 2